Liu Yong, Yang Chuanping, Cao Chengsong, Li Qing, Jin Xin, Shi Hanping
Department of Oncology, Xuzhou Central Hospital, Xuzhou School of Clinical Medicine, Nanjing Medical University, Xuzhou 221000, People's Republic of China.
Department of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou School of Clinical Medicine, Nanjing Medical University, Xuzhou 221000, People's Republic of China.
Onco Targets Ther. 2020 Jan 23;13:745-755. doi: 10.2147/OTT.S236162. eCollection 2020.
Circular RNA (circRNA) is involved in the development of various cancers. However, whether circRNA can inhibit the tumorigenesis of non-small cell lung cancer (NSCLC) is still unclear. We aimed to explore the epigenetic function of tumor-suppressive circRNA (hsa_circ_RNA_0011780) and its downstream regulatory factors in NSCLC.
Quantitative polymerase chain reaction (qPCR) was used to evaluate hsa_circ_11780 expression in NSCLC tissues and cell lines. The impact of high hsa_circ_11780 expression on overall survival in patients with NSCLC was tested using the Log rank test. The association between decreased hsa_circ_11780 expression and clinicopathological features in patients with NSCLC was analyzed using the Chi-squared test. In vitro cell proliferation and apoptosis were assayed using the cell counting kit-8 (CCK-8) and flow cytometry, respectively. Mice xenograft models were used to determine the tumor promoting effects of hsa_circ_11780 on NSCLC in vivo. The underlying regulatory mechanism was predicted by bioinformatics and verified by a dual-luciferase reporter assay, RNA transfection, qPCR, and Western blotting. The correlation between miR-544a and hsa_circ_11780 expression was verified using Spearman correlation coefficient.
The expression of hsa_circ_11780 in NSCLC tissues and cell lines strongly declined. Low hsa_circ_11780 expression is more likely to present in patients with a large tumor size (>3cm), distant metastasis, and poor overall survival. hsa_circ_11780 overexpression strongly inhibited proliferation, migration, and invasion of NSCLC cells (H226 and A549) in vitro and inhibited tumor growth in vivo. Furthermore, hsa_circ_11780 repressed miR-544a function by competitively binding to the complementary sites of miR-544a. miR-544a released by the declining expression of hsa_circ_11780 reduced the protein concentration of F-Box and WD repeat domain containing 7 (FBXW7) in NSCLC cells.
FBXW7 expression mediated by the hsa_circ_11780/miR-544a axis is markedly associated with the proliferation, migration, and invasion of NSCLC, resulting in decreased survival. These findings suggest that this regulatory axis may serve as a novel therapeutic target in NSCLC.
环状RNA(circRNA)参与多种癌症的发生发展。然而,circRNA是否能抑制非小细胞肺癌(NSCLC)的肿瘤发生仍不清楚。我们旨在探讨抑癌circRNA(hsa_circ_RNA_0011780)及其下游调控因子在NSCLC中的表观遗传功能。
采用定量聚合酶链反应(qPCR)评估hsa_circ_11780在NSCLC组织和细胞系中的表达。使用对数秩检验检测高hsa_circ_11780表达对NSCLC患者总生存期的影响。采用卡方检验分析hsa_circ_11780表达降低与NSCLC患者临床病理特征之间的相关性。分别使用细胞计数试剂盒-8(CCK-8)和流式细胞术检测体外细胞增殖和凋亡。利用小鼠异种移植模型确定hsa_circ_11780在体内对NSCLC的促肿瘤作用。通过生物信息学预测潜在的调控机制,并通过双荧光素酶报告基因检测、RNA转染、qPCR和蛋白质印迹法进行验证。使用Spearman相关系数验证miR-544a与hsa_circ_11780表达之间的相关性。
hsa_circ_11780在NSCLC组织和细胞系中的表达显著下降。hsa_circ_11780低表达更易出现在肿瘤体积较大(>3cm)、远处转移且总生存期较差的患者中。hsa_circ_11780过表达在体外强烈抑制NSCLC细胞(H226和A549)的增殖、迁移和侵袭,并在体内抑制肿瘤生长。此外,hsa_circ_11780通过竞争性结合miR-544a的互补位点抑制miR-544a的功能。hsa_circ_11780表达下降释放的miR-544a降低了NSCLC细胞中含F-Box和WD重复结构域7(FBXW7)的蛋白浓度。
hsa_circ_11780/miR-544a轴介导的FBXW7表达与NSCLC细胞的增殖、迁移和侵袭显著相关,导致生存期缩短。这些发现表明该调控轴可能成为NSCLC的一个新的治疗靶点。